반응식
[Cl:1][C:2]1[S:6][C:5]([S:7](Cl)(=[O:9])=[O:8])=[CH:4][CH:3]=1.BrC1SC(S(Cl)(=O)=O)=CC=1.[CH2:21]1[CH2:26][CH2:25][CH:24]([C@H:27]([NH2:31])[C:28](O)=[O:29])[CH2:23][CH2:22]1.CC(C1C=CC=CC=1)C(C(O)=O)N.N[C@H](C(O)=O)[C@@H](CC)C>>[Cl:1][C:2]1[S:6][C:5]([S:7]([NH:31][C@@H:27]([CH:24]2[CH2:25][CH2:26][CH2:21][CH2:22][CH2:23]2)[CH2:28][OH:29])(=[O:9])=[O:8])=[CH:4][CH:3]=1참가 물질
6
반응물 5
생성물 1
실험 절차
The following compounds (Examples 12-17, Table 4) were prepared using 5-chlorothiophene-2-sulfonyl chloride, and 5-bromothiophene-2-sulfonyl chloride with L-cyclohexylglycine, β-methyl-DL-phenylalanine, and L-allo-isoleucine and following the procedure outlined in Example 12.
후처리
- customThe following compounds (Examples 12-17, Table 4) were prepared
출처 및 근거
- ORD 기록
- ord-92d5e0741acd47eb98f36cb9f281c1a3
- 출처 데이터셋
- uspto-grants-2005_04
- 특허 번호
- US06878742B2
연결된 노트
불러오는 중…